In line with their hybrid epigenetic profile and their previously reported phenotype8, CIMP leukemias expressed both typical myeloid markers such as CD13, CD33, CD34 and KIT (Fig. 2c) and lymphoid markers like CD7 and CD3 (Fig. 2d). Here, CD33 is linked to leukemia.